Amneal Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.

About AMRX

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog.

CEO

Chintu Patel

CEOChintu Patel

Employees

8,300

Employees8,300

Headquarters

Bridgewater, New Jersey

HeadquartersBridgewater, New Jersey

Founded

2002

Founded2002

Employees

8,300

Employees8,300

AMRX Key Statistics

Market cap

3.02B

Market cap3.02B

Price-Earnings ratio

1.52K

Price-Earnings ratio1.52K

Dividend yield

—

Dividend yield—

Average volume

1.72M

Average volume1.72M

High today

$9.81

High today$9.81

Low today

$9.57

Low today$9.57

Open price

$9.72

Open price$9.72

Volume

2.26M

Volume2.26M

52 Week high

$10.34

52 Week high$10.34

52 Week low

$6.69

52 Week low$6.69

AMRX News

TipRanks 2d

Amneal Pharmaceuticals price target raised to $14 from $12 at JPMorgan

JPMorgan analyst Chris Schott raised the firm’s price target on Amneal Pharmaceuticals (AMRX) to $14 from $12 and keeps an Overweight rating on the shares. The...

Simply Wall St 4d

What Amneal Pharmaceuticals's FDA Exclusivity Win for Risperidone Injectable Means For Shareholders

Amneal Pharmaceuticals recently received U.S. FDA approval for two products: sodium oxybate oral solution for narcolepsy and risperidone extended-release inject...

Seeking Alpha 6d

Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem

Amneal Pharmaceuticals (NASDAQ:AMRX) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its generic product targeting Jazz Pharmace...

People also own

Based on the portfolios of people who own AMRX. This list is generated using Robinhood data, and it’s not a recommendation.